VitalConnect device improves at-home patient monitoring
August 21, 2018
Californian wearable biosensor technology firm VitalConnect has launched VistaTablet to increase its focus on at-home patient monitoring.
The mobile interface of the VistaTablet gives healthcare providers and patients access to vital sign data continuously acquired by the VitalPatch wearable biosensor regardless of patient location. The VitalPatch biosensor is an FDA-cleared Class 2 medical device that measures eight vital signs in real time.
The VistaTablet is a handheld mobile relay device that securely hosts and transmits the vital signs measured by the VitalPatch biosensor, presenting this data locally for the patient and to healthcare providers through the Vista platform. The mobility of the device supports timely remote analysis by caregivers for patients regardless if they are in hospital or at home.
The Vista platform allows physiological data for all patients to be easily accessible through the accompanying cloud-based application or viewed directly on the VistaTablet.
As a result of increasing healthcare costs, an increasing aging population (the number of 65 and over adults is expected to double by 2060), and demonstrated improved patient outcomes with advanced remote monitoring technologies, healthcare providers are beginning to shift eligible patients towards home care programmes.
Quality care traditionally found in a hospital has not been technologically or economically possible outside hospital walls on any significant scale until now. Vista with the mobile VistaTablet can help change that, enabling at home programmes to grow to meet the rising demands of quality home care. Within home care environments, admit-to-home patients receiving remote and continuous monitoring have shown a reduction in readmissions and an overall decrease in cost of care as compared with a traditional hospital stay.
Enabling patients to be admitted to home, rather than lengthy hospital stays, has been shown to decrease healthcare costs while improving patient outcomes.
"For acute care and the aging population, home hospital programmes offer an affordable solution to healthcare that works for providers and patients," said Nersi Nazari, CEO and founder of VitalConnect. "With the implementation of VistaTablet we are able to offer an easy-to-use mobile interface for physicians and patients to simultaneously monitor vital signs in real time, allowing patients to recover at home while still under the care of their doctor."
The launch of the device extends the Vista platform's capabilities into use outside the hospital walls.